HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum cyclophilin A concentrations and prognosis of acute intracerebral hemorrhage.

AbstractBACKGROUND:
Cyclophilin A is involved in brain injury. We investigated the relationship between serum cyclophilin A concentrations, hemorrhagic severity and clinical outcome in intracerebral hemorrhage (ICH).
METHODS:
We enrolled 105 ICH patients and 105 healthy individuals. Admission serum cyclophilin A concentrations were detected in ICH patients. Hemorrhagic severity was assessed using the National Institutes of Health Stroke Scale (NIHSS) and hematoma volume. Modified Rankin Scale score > 2 was defined as a poor outcome.
RESULTS:
Serum cyclophilin A concentrations were significantly higher in patients than in controls. There was a close correlation of serum cyclophilin A concentrations with NIHSS scores and hematoma volume. Serum cyclophilin A emerged as an independent predictor for 6-month mortality, overall survival and poor outcome. Moreover, it had a strong discriminatory ability for 6-month mortality and poor outcome. Furthermore, it could significantly improve the prognostic predictive ability of NIHSS scores or hematoma volume alone.
CONCLUSIONS:
Increasted serum cyclophilin A concentrations are highly associated with stroke severity and prognosis after hemorrhagic stroke.
AuthorsBin Chen, Jia Shen, Guan-Rong Zheng, Shen-Zhong Qiu, Huai-Ming Yin, Wei Mao, Hong-Xiang Wang, Jian-Bo Gao
JournalClinica chimica acta; international journal of clinical chemistry (Clin Chim Acta) Vol. 486 Pg. 162-167 (Nov 2018) ISSN: 1873-3492 [Electronic] Netherlands
PMID30077639 (Publication Type: Journal Article, Observational Study)
CopyrightCopyright © 2018 Elsevier B.V. All rights reserved.
Chemical References
  • Cyclophilin A
Topics
  • Acute Disease
  • Aged
  • Cerebral Hemorrhage (blood, diagnosis)
  • Cyclophilin A (blood)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: